Skip to main content
Clinical Trials/IRCT20201225049829N1
IRCT20201225049829N1CompletedPhase 3

Effect of oral betahistin in reducing of nausea and vomiting after laparoscopic cholecystectomy with general anesthesia

Mazandaran University of Medical Sciences0 sites120 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
15 years to 60 years (—)
Sex
All

Inclusion Criteria

  • The patient's desire to participate in the study and gain informed consent
  • Candidate for elective laparoscopic cholecystectomy
  • Age between 15 to 60 years
  • No history of betahistine allergy
  • No history of gastrointestinal disease and cardiovascular disease and respiratory problems

Exclusion Criteria

  • Patients with uncontrolled diabetes
  • Underlying gastrointestinal disease
  • History of nausea and vomiting and taking anti-nausea and vomiting drugs in 24 hours before surgery
  • Middle ear disease
  • Patients with BMI> 35
  • High blood pressure, cardiovascular disease, diarrhea with respiratory problems
  • If the laparoscopic surgery becomes an open cholecystectomy

Investigators

Similar Trials